These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development. de Villiers KA; Egan TJ Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570 [TBL] [Abstract][Full Text] [Related]
3. High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties. Huy NT; Chi PL; Nagai J; Dang TN; Mbanefo EC; Ahmed AM; Long NP; Thoa LT; Hung LP; Titouna A; Kamei K; Ueda H; Hirayama K Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919903 [TBL] [Abstract][Full Text] [Related]
4. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
5. Hemozoin and antimalarial drug discovery. Fong KY; Wright DW Future Med Chem; 2013 Aug; 5(12):1437-50. PubMed ID: 23919553 [TBL] [Abstract][Full Text] [Related]
6. Identification of β-hematin inhibitors in the MMV Malaria Box. Fong KY; Sandlin RD; Wright DW Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923 [TBL] [Abstract][Full Text] [Related]
7. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Tekwani BL; Walker LA Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198 [TBL] [Abstract][Full Text] [Related]
8. Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity. Sandlin RD; Fong KY; Wicht KJ; Carrell HM; Egan TJ; Wright DW Int J Parasitol Drugs Drug Resist; 2014 Dec; 4(3):316-25. PubMed ID: 25516843 [TBL] [Abstract][Full Text] [Related]
9. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related]
10. Natural products as starting points for future anti-malarial therapies: going back to our roots? Wells TN Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014 [TBL] [Abstract][Full Text] [Related]
11. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials. Tripathi AK; Gupta A; Garg SK; Tekwani BL Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077 [TBL] [Abstract][Full Text] [Related]
12. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
13. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Ncokazi KK; Egan TJ Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Evaluation of Novel Ferroquine and Phenylequine Analogues as Potential Antiplasmodial Agents. Jacobs L; de Kock C; de Villiers KA; Smith PJ; Smith VJ; van Otterlo WA; Blackie MA ChemMedChem; 2015 Dec; 10(12):2099-110. PubMed ID: 26447782 [TBL] [Abstract][Full Text] [Related]
15. Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties. Mosaddeque F; Mizukami S; Kamel MG; Teklemichael AA; Dat TV; Mizuta S; Toan DV; Ahmed AM; Vuong NL; Elhady MT; Giang HTN; Dang TN; Fukuda M; Huynh LK; Tanaka Y; Egan TJ; Kaneko O; Huy NT; Hirayama K Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439979 [TBL] [Abstract][Full Text] [Related]
17. Hemozoin (beta-hematin) Formation Inhibitors: Promising Target for the Development of New Antimalarials: Current Update and Future Prospect. Mali SN; Pandey A Comb Chem High Throughput Screen; 2022; 25(11):1859-1874. PubMed ID: 34565319 [TBL] [Abstract][Full Text] [Related]
18. Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum. Wicht KJ; Combrinck JM; Smith PJ; Hunter R; Egan TJ J Med Chem; 2016 Jul; 59(13):6512-30. PubMed ID: 27299916 [TBL] [Abstract][Full Text] [Related]
19. N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activity. Figueiras M; Coelho L; Wicht KJ; Santos SA; Lavrado J; Gut J; Rosenthal PJ; Nogueira F; Egan TJ; Moreira R; Paulo A Bioorg Med Chem; 2015 Apr; 23(7):1530-9. PubMed ID: 25725608 [TBL] [Abstract][Full Text] [Related]
20. Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation. Vargas S; Ndjoko Ioset K; Hay AE; Ioset JR; Wittlin S; Hostettmann K J Pharm Biomed Anal; 2011 Dec; 56(5):880-6. PubMed ID: 21872416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]